 | |
| Website | http://ecpo.org/ |
|---|---|
The European Cancer Prevention Organization (ECP) is a scientific organization representing physicians of all oncology sub-specialties with focus on cancer prevention. ECP was founded in 1981 with the support of several European scientists. The elected president of ECP is Professor Giovanni Corso. The Cancer Plan will aim to make at least 80% of the population aware of the Code by 2025.
ECP was created in 1981 to promote European cooperation in cancer prevention studies. At that time, several scientists had become convinced that lifestyle factors could be related to the risk of 60% or more of all human cancers, thus offering hope that many could be actually prevented. Alain Maskens, a Belgian oncologist, circulated a document that proposed to create an organization with three main goals:
Several experts agreed to form a scientific committee responsible for defining the project priorities, methods and structures. The Committee held its first meeting in Brussels on December 11 and 12, 1981. The participants included: Guy Blaudin de Thé (Lyon), Franco Conte (Genova), Daniela Daniele (Torino), Pierre Dellenbach (Strasbourg), Lajos Döbrössy (WHO Europe), Peter Ebbesen (Aarhus), Jean Faivre (Dijon), Pierre Jeandrain (Brussels), Joseph Joossens (Leuven), Cristina Kettlitz (Milano), Paul Mainguet (Louvain), Franz Oesch (Mainz), Marcel Roberfroid (Louvain), Leonardo Santi (Genova), James Scott (Leeds), Martine Van Glabbeke (EORTC), and Jean-Pierre Wolff (Villejuif). After a series of scientific presentations, the participants held discussions about methods and priorities, led by Prof. Scott, who became the first chairman of the ECP Scientific Committee. The main points which came out of this session were:
Alain Maskens received the responsibility of coordinating the project, as first medical coordinator.
In the months that followed, a legal ECP entity was created for managing the administrative aspects of the organization. The working groups started accruing members, and preparing joint research projects. A first symposium was organized in March 1983, soon to be followed by others on an annual basis.
An important event occurred 10 years later, in October 1991: the launch of the European Journal of Cancer Prevention, the official journal of ECP. This major achievement was led by Dr. Michael Hill, who had by then replaced James Scott as Chairman of the ECP Scientific Committee, and by Dr. Attilio Giacosa, who had replaced Dr. Maskens as medical coordinator of ECP.
The aim of ECP has progressively changed, currently it includes epidemiology, nutrition, genetics, molecular biology, targeted therapies, surgery, and innovative research areas. Members come from different European countries, and they organize an annual meeting to discuss about progress in cancer prevention and novel research projects.
ECP offers several educational opportunities for physicians. These activities comprise scientific meetings, educational conferences, professional workshops, and special symposia about issues of particular relevance to oncologists and researchers. [1] [2] In 1992, the European Journal of Cancer Prevention was created and affiliated to the ECP organization as official journal. [3]
The National Institutes of Health, commonly referred to as NIH, is the primary agency of the United States government responsible for biomedical and public health research. It was founded in the late 1880s and is now part of the United States Department of Health and Human Services. Many NIH facilities are located in Bethesda, Maryland, and other nearby suburbs of the Washington metropolitan area, with other primary facilities in the Research Triangle Park in North Carolina and smaller satellite facilities located around the United States. The NIH conducts its own scientific research through the NIH Intramural Research Program (IRP) and provides major biomedical research funding to non-NIH research facilities through its Extramural Research Program.
Tianjin Medical University is a municipal public medical university in Tianjin, China. It is affiliated with the City of Tianjin, and co-funded by the Tianjin Municipal People's Government, the National Health Commission, and the Ministry of Education. The university is part of Project 211 and the Double First-Class Construction.
M. Krishnan Nair was an Indian oncologist. He was the founding director of the Regional Cancer Centre, Thiruvananthapuram, a director of the S.U.T. Institute of Oncology, and Trivandrum Cancer Center(TCC), part of SUT Royal Hospital in Thiruvananthapuram (Trivandrum) and a professor at the Amrita Institute of Medical Sciences & Research in Kochi. The Government of India awarded him the fourth highest civilian award of the Padma Shri in 2001 for his contributions in the cancer care field.
The European Organisation for Research and Treatment of Cancer (EORTC) is a unique pan-European non-profit clinical cancer research organisation established in 1962 operating as an international association under Belgium law. It develops, conducts, coordinates and stimulates high-quality translational and clinical trial research to improve the survival and quality of life of cancer patients. This is achieved through the development of new drugs and other innovative approaches, and the testing of more effective therapeutic strategies, using currently approved drugs, surgery and/or radiotherapy in clinical trials conducted under the auspices of a vast network of clinical cancer researchers supported by 220 staff members based in Brussels. The EORTC has the expertise to conduct large and complex trials especially specific populations such as the older patient and rare tumours.
The International Federation of Medical Students' Associations (IFMSA) is a non-governmental organization representing associations of medical students. It was founded in May 1951 and currently maintains 139 member organizations from 130 countries around.
The Society of Gynecologic Oncology (SGO), headquartered in Chicago, Illinois, is the premier medical specialty society for health care professionals trained in the comprehensive management of gynecologic cancers, affecting the uterus, fallopian tubes, ovaries, cervix, vagina, and vulva. As a 501(c)(6) organization, the SGO contributes to the advancement of women’s cancer care by encouraging research, providing education, raising standards of practice, advocating for patients and members and collaborating with other domestic and international organizations.
The Global Health Security Initiative (GHSI) is an informal international partnership among countries in order to exchange information and coordinate practices for confronting new threats and risks to global health. It was formed to respond to threats of biological, chemical, or radio-nuclear terrorism (CBRN), with pandemic influenza added to the scope a year later.
The European Institute for Biomedical Imaging Research (EIBIR) was established in 2006 as a non-profit, limited liability company on the initiative of the European Society of Radiology with funding of the European Commission within the Sixth Framework Programme.
André Gernez was a French physician, oncologist, and radiologist. His work has received criticism from other medical professionals as being unscientific, or alternative medicine.
The European Society of Gynaecological Oncology (ESGO) is a Europe-wide society of health care professionals and researchers specializing in the study, prevention, treatment and care of gynaecological cancers. The society, which has more than 2,600 members worldwide, was founded in Venice, Italy, in 1983.
Geriatric oncology is a branch of medicine that is concerned with the diagnosis and treatment of cancer in the elderly, usually defined as aged 65 and older. This fairly young but increasingly important subspecialty incorporates the special needs of the elderly into the treatment of cancer.
The European Association of Urology (EAU) is a non-profit organisation committed to the representation of urology professionals worldwide. All active urology professionals, including urology nurses, are eligible for membership of the EAU.
Oncology is a branch of medicine that deals with the study, treatment, diagnosis, and prevention of cancer. A medical professional who practices oncology is an oncologist. The name's etymological origin is the Greek word ὄγκος (ónkos), meaning "tumor", "volume" or "mass". Oncology is concerned with:
The American Society of Tropical Medicine and Hygiene (ASTMH) is an Arlington, Virginia-based non-profit organization of scientists, clinicians, students and program professionals whose longstanding mission is to promote global health through the prevention and control of infectious and other diseases that disproportionately afflict the global poor. ASTMH members work in areas of research, health care and education that encompass laboratory science, international field studies, clinical care and country-wide programs of disease control. The current organization was formed in 1951 with the amalgamation of the American Society of Tropical Medicine, founded in 1903, and the National Malaria Society, founded in 1941.
Peter Boyle, FRSE FFPH FRCPS(Glas) FRCP(Edin) FMedSci, was a British epidemiologist. He conducted research on globalisation of cancer, where he showed the dramatic increase of cancer in low- and medium income countries.
Paolo Boffetta is an Italian epidemiologist. He is doing research on cancer and other chronic diseases, where he contributed to the understanding of the role of occupation, environment, alcohol, smoking and nutrition in disease development.
Philippe Autier is a Belgian epidemiologist. He is doing research on cancer, where he contributed to the understanding of the role of UV exposure in cancer development.
Carlo La Vecchia is an Italian epidemiologist. He is doing research on chronic diseases, where he contributed to the understanding of the risks related to diet, tobacco, oral contraceptive use and occupational or environmental exposure to toxic substances in cancer and other chronic diseases development.
The International Human Epigenome Consortium (IHEC) is a scientific organization, founded in 2010, that helps to coordinate global efforts in the field of Epigenomics. The initial goal was to generate at least 1,000 reference (baseline) human epigenomes from different types of normal and disease-related human cell types.
The European Federation of Organisations for Medical Physics (EFOMP) was founded in May 1980 in London to serve as an umbrella organisation representing the national Medical Physics societies in Europe. The office moved to Utrecht in January 2021. It is a non-profit organisation and aims to foster and coordinate the activities of its national member organisations, encourage exchange and dissemination of professional and scientific information, develop guidelines for education, training and accreditation programmes and to make recommendations on the responsibilities, organisational relationships and roles of medical physicists.